Yüklüyor......
Ertugliflozin in the treatment of type 2 diabetes mellitus
More than 422 million people worldwide have diabetes, with 90–95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in microvascular complications but recent data have demonstrated improvements in macrovascular outcomes with sodium–glucose cotransporter 2 (SGLT2) inhi...
Kaydedildi:
| Yayımlandı: | Drugs Context |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioExcel Publishing Ltd
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7707814/ https://ncbi.nlm.nih.gov/pubmed/33293984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-7-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|